spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalton, B. A.
Right arrow Articles by Steele, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalton, B. A.
Right arrow Articles by Steele, J. G.

Journal of Cell Science, Vol 108, Issue 5 2083-2092, Copyright © 1995 by Company of Biologists


JOURNAL ARTICLES

Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells

BA Dalton, CD McFarland, PA Underwood and JG Steele
CSIRO Division of Biomolecular Engineering, Sydney Laboratory, North Ryde, NSW, Australia.

Human bone-derived cells are known to attach and spread on surfaces which have been precoated with fibronectin, but the contributions made by specific domains of the molecule have not yet been defined. Here we refer to the osteoblast-like cells as human bone cells. We have determined the relevance of separate regions of fibronectin, particularly the heparin-binding region, for the initial attachment and spreading of these cells. Human bone cells attached to fragments from each of the cell- and heparin-binding regions of fibronectin, but failed to attach to a fragment from the gelatin-binding region. Bovine corneal epithelial cells, which were included as an example of an alternative primary cell strain, attached to the cell-binding fragment but showed no specific short-term attachment to the heparin or gelatin-binding fragments. Monoclonal antibody MAb17, which binds to the cell binding region of fibronectin, partially inhibited the attachment of both human bone cells and corneal epithelial cells to intact fibronectin when present at 50 micrograms/ml and reduced human bone cell attachment to the cell-binding region fragment of fibronectin. Monoclonal antibody, MAb 32, which binds to the heparin-binding region of fibronectin, failed to inhibit attachment of the human bone cells to fibronectin but reduced the attachment of these cells to the heparin-binding region fragment. Heparin and chondroitin sulphate were able to inhibit human bone cell attachment to the heparin-binding fragment of fibronectin but had no effect on their attachment to intact fibronectin or the cell-binding region of fibronectin. Immunofluorescent staining and confocal microscopy showed extensive spreading and actin filament formation when human bone cells were cultured on intact fibronectin. Cells cultured on the heparin-binding fragment showed only minimal spreading coinciding with less extensive actin filament organisation. On the cell-binding fragment of fibronectin more spreading was seen than on the heparin-binding fragment but it was not as extensive as on intact fibronectin. Taken together, these data suggest that human bone cells, unlike bovine corneal epithelial cells, have an attachment mechanism for the heparin-binding region of fibronectin. Attachment to this region is probably mediated by cell surface proteoglycans. However, interaction with the cell-binding domain is required for effective cell spreading of human bone cells on fibronectin during the first 90 minutes after seeding into culture.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q. Chen, P. Sivakumar, C. Barley, D. M. Peters, R. R. Gomes, M. C. Farach-Carson, and S. L. Dallas
Potential Role for Heparan Sulfate Proteoglycans in Regulation of Transforming Growth Factor-beta (TGF-beta) by Modulating Assembly of Latent TGF-beta-binding Protein-1
J. Biol. Chem., September 7, 2007; 282(36): 26418 - 26430.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. F. Sweeney, R. Z. Xie, M. D. M. Evans, A. Vannas, S. D. Tout, H. J. Griesser, G. Johnson, and J. G. Steele
A Comparison of Biological Coatings for the Promotion of Corneal Epithelialization of Synthetic Surface In Vivo
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3301 - 3309.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Sachchidanand, O. Lequin, D. Staunton, B. Mulloy, M. J. Forster, K. Yoshida, and I. D. Campbell
Mapping the Heparin-binding Site on the 13-14F3 Fragment of Fibronectin
J. Biol. Chem., December 20, 2002; 277(52): 50629 - 50635.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. Moursi, C. Damsky, J Lull, D Zimmerman, S. Doty, S Aota, and R. Globus
Fibronectin regulates calvarial osteoblast differentiation
J. Cell Sci., January 6, 1996; 109(6): 1369 - 1380.
[Abstract] [PDF]




© The Company of Biologists Ltd 1995